Report cover image

Pharmaceutical Packaging Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2032

Published Apr 03, 2026
Length 190 Pages
SKU # PERR21067732

Description

Persistence Market Research has recently released a comprehensive report on the global Pharmaceutical Packaging Market, providing an in-depth analysis of key market dynamics, including growth drivers, emerging trends, opportunities, and challenges. The report provides a clear understanding of the market landscape, enabling stakeholders to make informed strategic decisions.

Key Insights:
  • Pharmaceutical Packaging Market Size (2025E): US$ 131.2 Bn
  • Projected Market Value (2032F): US$ 198.7 Bn
  • Global Market Growth Rate (CAGR 2025 to 2032): 6.1%
Pharmaceutical Packaging Market – Report Scope:

The pharmaceutical packaging market covers a wide array of materials, packaging types, and delivery systems designed to ensure drug safety, efficacy, and compliance with regulatory standards. Packaging solutions protect pharmaceuticals from contamination, degradation, and tampering while facilitating accurate dosing and ease of use. Increasing demand for biologics, injectable drugs, and oral medications, along with stringent regulatory requirements for product safety and shelf-life stability, is driving market expansion. The growth of e-commerce in healthcare and the rising adoption of innovative packaging solutions such as prefillable inhalers, blister packs, and biopolymer-based materials further strengthen market prospects.

Market Growth Drivers:

Several factors are propelling growth in the global pharmaceutical packaging market. Rising pharmaceutical production and an increasing number of new drug launches worldwide are driving demand for primary, secondary, and tertiary packaging solutions. The growing focus on patient safety, regulatory compliance, and product traceability is promoting the adoption of advanced packaging materials and technologies. Innovations in packaging design, such as child-resistant closures, tamper-evident features, and smart packaging with tracking and monitoring capabilities, are further enhancing market appeal. Additionally, the growth of the global healthcare industry and increasing consumer preference for convenience in medication handling and storage are supporting sustained market expansion.

Market Restraints:

Despite positive growth prospects, the pharmaceutical packaging market faces several challenges. The high cost of advanced packaging materials and specialized production equipment can limit adoption, especially in cost-sensitive regions. Complex regulatory frameworks and the need for compliance with diverse global standards may slow down product approvals and increase operational challenges for manufacturers. Volatility in raw material prices, including plastics, glass, and metals, can impact production costs and profitability. Moreover, environmental concerns regarding non-biodegradable packaging materials are prompting the industry to explore sustainable alternatives, which may require significant investment.

Market Opportunities:

The pharmaceutical packaging market offers numerous growth opportunities, fueled by innovation and technological advancement. The rising demand for biologics, vaccines, and personalized medicines is creating a need for specialized packaging solutions such as prefilled syringes, inhalers, and advanced drug delivery systems. Emerging markets in Asia-Pacific and Latin America present significant growth potential due to expanding healthcare infrastructure, increasing pharmaceutical production, and rising awareness about drug safety. The shift toward sustainable and biodegradable packaging materials, coupled with the integration of smart technologies like RFID tags and serialization, presents opportunities for market players to differentiate their products and gain a competitive edge. Strategic collaborations, mergers, and acquisitions further enhance the potential for market expansion.

Key Questions Answered in the Report:
  • What are the primary factors driving the global pharmaceutical packaging market’s growth?
  • Which regions and market segments are witnessing the highest demand for pharmaceutical packaging solutions?
  • How are innovations in packaging technologies influencing market dynamics?
  • Who are the key players in the pharmaceutical packaging market, and what strategies are they adopting to maintain competitiveness?
  • What are the emerging trends and future projections for the global pharmaceutical packaging market?
Competitive Intelligence and Business Strategy:

Leading companies in the pharmaceutical packaging market, such as Amcor plc, Becton, Dickinson, and Company, AptarGroup, Inc., Drug Plastics Group, Gerresheimer AG, Schott AG, Owens-Illinois, Inc., West Pharmaceutical Services, Inc., Berry Global, Inc., WestRock Company, SGD Pharma, International Paper, Comar, LLC, CCL Industries, Inc., and Vetter Pharma International, are investing in product innovation, advanced materials, and sustainable packaging solutions. These companies are enhancing their offerings in primary, secondary, and tertiary packaging for oral, injectable, ophthalmic, and other drug delivery systems. Strengthening distribution networks, collaborating with pharmaceutical manufacturers, and focusing on regulatory compliance enable them to maintain a strong market presence and expand global reach.

Companies Covered in This Report:
  • Amcor plc
  • Becton, Dickinson, and Company
  • AptarGroup, Inc.
  • Drug Plastics Group
  • Gerresheimer AG
  • Schott AG
  • Owens-Illinois, Inc.
  • West Pharmaceutical Services, Inc.
  • Berry Global, Inc.
  • WestRock Company
  • SGD Pharma
  • International Paper
  • Comar, LLC
  • CCL Industries, Inc.
  • Vetter Pharma International
  • Others
Market Segmentation

By Material
  • Plastics (HDPE, LDPE, LLDPE, PET, Other Plastics)
  • Glass (Type I Borosilicate, Type II Treated Soda-lime, Type III Soda-lime)
  • Metal
  • Paper and Paperboard
  • Biopolymers and Other Materials
By Packaging
  • Primary (Plastic Bottles, Caps & Closures, Parenteral Containers, Blister Packs, Prefillable Inhalers, Pouches, Medication Tubes, Others)
  • Secondary (Prescription Containers, Pharmaceutical Packaging Accessories)
  • Tertiary
By Drug Delivery
  • Ophthalmic
  • Injectable
  • IV drugs
  • Nasal
  • Wound care
  • Pulmonary
  • Oral
  • Others
By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa


Please Note: It will take 5 business days to complete the report upon order confirmation.

Table of Contents

190 Pages
1. Executive Summary
1.1. Global Pharmaceutical Packaging Market Snapshot, 2025 and 2032
1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. COVID-19 Impact Analysis
2.4. Forecast Factors - Relevance and Impact
3. Value Added Insights
3.1. Value Chain Analysis
3.2. Key Market Players
3.3. Regulatory Landscape
3.4. PESTLE Analysis
3.5. Porter’s Five Forces Analysis
3.6. Consumer Behavior Analysis
4. Price Trend Analysis, 2019 - 2032
4.1. Key Factors Impacting Product Prices
4.2. Pricing Analysis, By Packaging
4.3. Regional Prices and Product Preferences
5. Global Pharmaceutical Packaging Market Outlook
5.1. Market Size (US$ Bn) Analysis and Forecast
5.1.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
5.1.2. Market Size (US$ Bn) Analysis and Forecast, 2025-2032
5.2. Global Pharmaceutical Packaging Market Outlook: Material
5.2.1. Historical Market Size (US$ Bn) Analysis, By Material, 2019-2024
5.2.2. Market Size (US$ Bn) Analysis and Forecast, By Material, 2025-2032
5.2.2.1. Oral
5.2.2.2. Glass (Type I Borosilicate, Type II Treated Soda-lime, Type III Soda-lime)
5.2.2.3. Metal
5.2.2.4. Paper and Paperboard
5.2.2.5. Biopolymers and Other Materials
5.2.3. Market Attractiveness Analysis: Material
5.3. Global Pharmaceutical Packaging Market Outlook: Packaging
5.3.1. Historical Market Size (US$ Bn) Analysis, By Packaging, 2019-2024
5.3.2. Market Size (US$ Bn) Analysis and Forecast, By Packaging, 2025-2032
5.3.2.1. Primary (Plastic Bottles, Caps & Closures, Parenteral Containers, Blister Packs, Prefillable Inhalers, Pouches, Medication Tubes, Others)
5.3.2.2. Secondary (Prescription Containers, Pharmaceutical Packaging Accessories)
5.3.2.3. Tertiary
5.3.3. Market Attractiveness Analysis: Packaging
5.4. Global Pharmaceutical Packaging Market Outlook: Drug Delivery
5.4.1. Historical Market Size (US$ Bn) Analysis, By Drug Delivery, 2019-2024
5.4.2. Market Size (US$ Bn) Analysis and Forecast, By Drug Delivery, 2025-2032
5.4.2.1. Ophthalmic
5.4.2.2. Injectable
5.4.2.3. IV Drugs
5.4.2.4. Nasal
5.4.2.5. Wound care
5.4.2.6. Pulmonary
5.4.2.7. Plastics (HDPE, LDPE, LLDPE, PET, Other Plastics)
5.4.2.8. Others
5.4.3. Market Attractiveness Analysis: Drug Delivery
6. Global Pharmaceutical Packaging Market Outlook: Region
6.1. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2024
6.2. Market Size (US$ Bn) Analysis and Forecast, By Region, 2025-2032
6.2.1. North America
6.2.2. Latin America
6.2.3. Europe
6.2.4. East Asia
6.2.5. South Asia and Oceania
6.2.6. Middle East & Africa
6.3. Market Attractiveness Analysis: Region
7. North America Pharmaceutical Packaging Market Outlook
7.1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
7.1.1. By Country
7.1.2. By Material
7.1.3. By Packaging
7.1.4. By Packaging
7.2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
7.2.1. U.S.
7.2.2. Canada
7.3. Market Size (US$ Bn) Analysis and Forecast, By Material, 2025-2032
7.3.1. Oral
7.3.2. Glass (Type I Borosilicate, Type II Treated Soda-lime, Type III Soda-lime)
7.3.3. Metals
7.3.4. Paper and Paperboard
7.3.5. Biopolymers and Other Materials
7.3.6. Others
7.4. Market Size (US$ Bn) Analysis and Forecast, By Packaging, 2025-2032
7.4.1. Primary (Plastic Bottles, Caps & Closures, Parenteral Containers, Blister Packs, Prefillable Inhalers, Pouches, Medication Tubes, Others)
7.4.2. Secondary (Prescription Containers, Pharmaceutical Packaging Accessories)
7.4.3. Tertiary
7.5. Market Size (US$ Bn) Analysis and Forecast, By Drug Delivery, 2025-2032
7.5.1. Ophthalmic
7.5.2. Injectable
7.5.3. IV Drugs
7.5.4. Nasal
7.5.5. Wound care
7.5.6. Pulmonary
7.5.7. Plastics (HDPE, LDPE, LLDPE, PET, Other Plastics)
7.5.8. Others
7.6. Market Attractiveness Analysis
8. Europe Pharmaceutical Packaging Market Outlook
8.1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
8.1.1. By Country
8.1.2. By Material
8.1.3. By Packaging
8.1.4. By Drug Delivery
8.2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
8.2.1. Germany
8.2.2. France
8.2.3. U.K.
8.2.4. Italy
8.2.5. Spain
8.2.6. Russia
8.2.7. Rest of Europe
8.3. Market Size (US$ Bn) Analysis and Forecast, By Expression System, 2025-2032
8.3.1. Oral
8.3.2. Glass (Type I Borosilicate, Type II Treated Soda-lime, Type III Soda-lime)
8.3.3. Metal
8.3.4. Paper and Paperboard
8.3.5. Biopolymers and Other Materials
8.4. Market Size (US$ Bn) Analysis and Forecast, By Packaging, 2025-2032
8.4.1. Primary (Plastic Bottles, Caps & Closures, Parenteral Containers, Blister Packs, Prefillable Inhalers, Pouches, Medication Tubes, Others)
8.4.2. Secondary (Prescription Containers, Pharmaceutical Packaging Accessories)
8.4.3. Tertiary
8.5. Market Size (US$ Bn) Analysis and Forecast, By Drug Delivery, 2025-2032
8.5.1. Ophthalmic
8.5.2. Injectable
8.5.3. IV Drugs
8.5.4. Nasal
8.5.5. Wound care
8.5.6. Pulmonary
8.5.7. Plastics (HDPE, LDPE, LLDPE, PET, Other Plastics)
8.5.8. Others
8.6. Market Attractiveness Analysis
9. East Asia Pharmaceutical Packaging Market Outlook
9.1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
9.1.1. By Country
9.1.2. By Material
9.1.3. By Packaging
9.1.4. By Drug Delivery
9.2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
9.2.1. China
9.2.2. Japan
9.2.3. South Korea
9.3. Market Size (US$ Bn) Analysis and Forecast, By Material, 2025-2032
9.3.1. Oral
9.3.2. Glass (Type I Borosilicate, Type II Treated Soda-lime, Type III Soda-lime)
9.3.3. Metal
9.3.4. Paper and Paperboard
9.3.5. Biopolymers and Other Materials
9.4. Market Size (US$ Bn) Analysis and Forecast, By Packaging, 2025-2032
9.4.1. Primary (Plastic Bottles, Caps & Closures, Parenteral Containers, Blister Packs, Prefillable Inhalers, Pouches, Medication Tubes, Others)
9.4.2. Secondary (Prescription Containers, Pharmaceutical Packaging Accessories)
9.4.3. Tertiary
9.5. Market Size (US$ Bn) Analysis and Forecast, By Drug Delivery, 2025-2032
9.5.1. Ophthalmic
9.5.2. Injectable
9.5.3. IV Drugs
9.5.4. Nasal
9.5.5. Wound care
9.5.6. Pulmonary
9.5.7. Plastics (HDPE, LDPE, LLDPE, PET, Other Plastics)
9.5.8. Others
9.6. Market Attractiveness Analysis
10. South Asia & Oceania Pharmaceutical Packaging Market Outlook
10.1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
10.1.1. By Country
10.1.2. By Material
10.1.3. By Packaging
10.1.4. By Drug Delivery
10.2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
10.2.1. India
10.2.2. Indonesia
10.2.3. Thailand
10.2.4. Singapore
10.2.5. ANZ
10.2.6. Rest of South Asia & Oceania
10.3. Market Size (US$ Bn) Analysis and Forecast, By Material, 2025-2032
10.3.1. Oral
10.3.2. Glass (Type I Borosilicate, Type II Treated Soda-lime, Type III Soda-lime)
10.3.3. Metal
10.3.4. Paper and Paperboard
10.3.5. Biopolymers and Other Materials
10.3.6. Others
10.4. Market Size (US$ Bn) Analysis and Forecast, By Packaging, 2025-2032
10.4.1. Primary (Plastic Bottles, Caps & Closures, Parenteral Containers, Blister Packs, Prefillable Inhalers, Pouches, Medication Tubes, Others)
10.4.2. Secondary (Prescription Containers, Pharmaceutical Packaging Accessories)
10.4.3. Tertiary
10.5. Market Size (US$ Bn) Analysis and Forecast, By Drug Delivery, 2025-2032
10.5.1. Ophthalmic
10.5.2. Injectable
10.5.3. IV Drugs
10.5.4. Nasal
10.5.5. Wound care
10.5.6. Pulmonary
10.5.7. Plastics (HDPE, LDPE, LLDPE, PET, Other Plastics)
10.5.8. Others
10.6. Market Attractiveness Analysis
11. Latin America Pharmaceutical Packaging Market Outlook
11.1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
11.1.1. By Country
11.1.2. By Material
11.1.3. By Packaging
11.1.4. By Drug Delivery
11.2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
11.2.1. Brazil
11.2.2. Mexico
11.2.3. Rest of Latin America
11.3. Market Size (US$ Bn) Analysis and Forecast, By Expression System, 2025-2032
11.3.1. Oral
11.3.2. Glass (Type I Borosilicate, Type II Treated Soda-lime, Type III Soda-lime)
11.3.3. Metal
11.3.4. Paper and Paperboard
11.3.5. Biopolymers and Other Materials
11.4. Market Size (US$ Bn) Analysis and Forecast, By Packaging, 2025-2032
11.4.1. Primary (Plastic Bottles, Caps & Closures, Parenteral Containers, Blister Packs, Prefillable Inhalers, Pouches, Medication Tubes, Others)
11.4.2. Secondary (Prescription Containers, Pharmaceutical Packaging Accessories)
11.4.3. Tertiary
11.5. Market Size (US$ Bn) Analysis and Forecast, By Drug Delivery, 2025-2032
11.5.1. Ophthalmic
11.5.2. Injectable
11.5.3. IV Drugs
11.5.4. Nasal
11.5.5. Wound care
11.5.6. Pulmonary
11.5.7. Plastics (HDPE, LDPE, LLDPE, PET, Other Plastics)
11.5.8. Others
11.6. Market Attractiveness Analysis
12. Middle East & Africa Pharmaceutical Packaging Market Outlook
12.1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
12.1.1. By Country
12.1.2. By Expression System
12.1.3. By Packaging
12.1.4. By Drug Delivery
12.2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
12.2.1. GCC Countries
12.2.2. Egypt
12.2.3. South Africa
12.2.4. Northern Africa
12.2.5. Rest of Middle East & Africa
12.3. Market Size (US$ Bn) Analysis and Forecast, By Expression System, 2025-2032
12.3.1. Oral
12.3.2. Glass (Type I Borosilicate, Type II Treated Soda-lime, Type III Soda-lime)
12.3.3. Metal
12.3.4. Paper and Paperboard
12.3.5. Biopolymers and Other Materials
12.3.6. Others
12.4. Market Size (US$ Bn) Analysis and Forecast, By Packaging, 2025-2032
12.4.1. Primary (Plastic Bottles, Caps & Closures, Parenteral Containers, Blister Packs, Prefillable Inhalers, Pouches, Medication Tubes, Others)
12.4.2. Secondary (Prescription Containers, Pharmaceutical Packaging Accessories)
12.4.3. Tertiary
12.5. Market Size (US$ Bn) Analysis and Forecast, By Drug Delivery, 2025-2032
12.5.1. Ophthalmic
12.5.2. Injectable
12.5.3. IV Drugs
12.5.4. Nasal
12.5.5. Wound care
12.5.6. Pulmonary
12.5.7. Plastics (HDPE, LDPE, LLDPE, PET, Other Plastics)
12.5.8. Others
12.6. Market Attractiveness Analysis
13. Competition Landscape
13.1. Market Share Analysis, 2024
13.2. Market Structure
13.2.1. Competition Intensity Mapping By Market
13.2.2. Competition Dashboard
13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
13.3.1. Amcor plc
13.3.1.1. Overview
13.3.1.2. Segments and Packaging
13.3.1.3. Key Financials
13.3.1.4. Market Developments
13.3.1.5. Market Strategy
13.3.2. Becton, Dickinson, and Company
13.3.3. AptarGroup, Inc.
13.3.4. Drug Plastics Group
13.3.5. Gerresheimer AG
13.3.6. Schott AG
13.3.7. Owens Illinois, Inc.
13.3.8. West Pharmaceutical Services, Inc.
13.3.9. Berry Global, Inc.
13.3.10. WestRock Company
13.3.11. SGD Pharma
13.3.12. International Paper
13.3.13. Comar, LLC
13.3.14. CCL Industries, Inc.
13.3.15. Vetter Pharma International
13.3.16. Others
14. Appendix
14.1. Research Methodology
14.2. Research Assumptions
14.3. Acronyms and Abbreviations
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.